Aaron Siri

If they're going to have an immune dysregulation, if they're going to have a developmental issue, you're not going to know that for years. Asthma is not even diagnosed until a few years of age. Developmental issues take years. And so, you know, a lot of the issues that we see, I mentioned, you know, my firm's got about 40 people that just do vaccine work.

If they're going to have an immune dysregulation, if they're going to have a developmental issue, you're not going to know that for years. Asthma is not even diagnosed until a few years of age. Developmental issues take years. And so, you know, a lot of the issues that we see, I mentioned, you know, my firm's got about 40 people that just do vaccine work.

We do other things, but they just do vaccine work. And we don't represent pharmaceutical companies. So as far as I know, we have the biggest...

We do other things, but they just do vaccine work. And we don't represent pharmaceutical companies. So as far as I know, we have the biggest...

We do other things, but they just do vaccine work. And we don't represent pharmaceutical companies. So as far as I know, we have the biggest...

vaccine practice in the world that doesn't represent pharmaceutical companies one of the practices we have is vaccine injury claims we don't see pharmaceutical companies you can't they have immunity to liability since 1986 the only product like that but you can't see the federal health authorities in this little program and so you know are a lot of the injuries that we see when we do that work are immune or immune mediated neurological disorders

vaccine practice in the world that doesn't represent pharmaceutical companies one of the practices we have is vaccine injury claims we don't see pharmaceutical companies you can't they have immunity to liability since 1986 the only product like that but you can't see the federal health authorities in this little program and so you know are a lot of the injuries that we see when we do that work are immune or immune mediated neurological disorders

vaccine practice in the world that doesn't represent pharmaceutical companies one of the practices we have is vaccine injury claims we don't see pharmaceutical companies you can't they have immunity to liability since 1986 the only product like that but you can't see the federal health authorities in this little program and so you know are a lot of the injuries that we see when we do that work are immune or immune mediated neurological disorders

And those things are not going to appear until typically a few days after vaccination. So this trial, going back to this polio vaccine that was the subject of this petition, it was utterly useless to determine its safety.

And those things are not going to appear until typically a few days after vaccination. So this trial, going back to this polio vaccine that was the subject of this petition, it was utterly useless to determine its safety.

And those things are not going to appear until typically a few days after vaccination. So this trial, going back to this polio vaccine that was the subject of this petition, it was utterly useless to determine its safety.

You know, that's an excellent question. Why would the FDA agree to license it, right? It's a great question. We could talk about regulatory capture. We could talk about the ideological beliefs that the folks who are involved in CBER, which is the biologics division of the FDA. And within that, there's an office called the OVVR. That's where the vaccines are actually, licenses are reviewed.

You know, that's an excellent question. Why would the FDA agree to license it, right? It's a great question. We could talk about regulatory capture. We could talk about the ideological beliefs that the folks who are involved in CBER, which is the biologics division of the FDA. And within that, there's an office called the OVVR. That's where the vaccines are actually, licenses are reviewed.

You know, that's an excellent question. Why would the FDA agree to license it, right? It's a great question. We could talk about regulatory capture. We could talk about the ideological beliefs that the folks who are involved in CBER, which is the biologics division of the FDA. And within that, there's an office called the OVVR. That's where the vaccines are actually, licenses are reviewed.

And I've met some of the folks who've been in that department, and they're very much I don't know if the right, I guess, ideologues, they believe almost a priority in the safety of these products, even when they're experimental to such a degree that I guess they let products like this. And I should tell you, if you think that

And I've met some of the folks who've been in that department, and they're very much I don't know if the right, I guess, ideologues, they believe almost a priority in the safety of these products, even when they're experimental to such a degree that I guess they let products like this. And I should tell you, if you think that

And I've met some of the folks who've been in that department, and they're very much I don't know if the right, I guess, ideologues, they believe almost a priority in the safety of these products, even when they're experimental to such a degree that I guess they let products like this. And I should tell you, if you think that

I'm speculating, right? The important point is they did it. Why they did it, we could speculate on, but they did it.

I'm speculating, right? The important point is they did it. Why they did it, we could speculate on, but they did it.

I'm speculating, right? The important point is they did it. Why they did it, we could speculate on, but they did it.